YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced that its ...
Commercial and Clinical Progress YD Bio highlighted its dual-track approach to eye care, featuring both market-ready products and innovative clinical developments: Exovisse™ Eye Care: Developed in ...
2don MSN
Two ways to read a genome: Body-wide, single-cell atlas maps DNA folding and methylation together
Every cell in the human body carries the same 3 billion letters of DNA, yet a neuron, a heart muscle cell and a pancreatic beta cell each use that shared code to do entirely different jobs. How cells ...
Scientists at the Peter MacCallum Cancer Center have uncovered new insights into how cells regulate DNA methylation, a ...
DNA methylation is an epigenetic modification crucial to normal development, with its dysregulation leading to various diseases including cancer. As interest in epigenomics grows, an innovative ...
DNA and RNA methylation, initially thought to operate as distinct pathways, have been shown to interact closely, shifting our understanding of gene regulation. A team of researchers from the ...
A new research paper was published in Aging (Aging-US) Volume 17, Issue 3, on March 12, 2025, titled "DNA methylation entropy is a biomarker for aging." Researchers Jonathan Chan, Liudmilla Rubbi, and ...
YD Bio Limited ("YD Bio" or the "Company") (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results